Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England.

by Albert Jan van Hoek, Elizabeth Miller
Published 2016-01-01

Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes

by Pieter T. de Boer, Jantien A. Backer, Albert Jan van Hoek, Jacco Wallinga
Published 2020-01-01

Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence

by Stephan Miehlke, Alfredo J. Lucendo, Alex Straumann, Albert Jan Bredenoord, Stephen Attwood
Published 2020-06-01

Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control

by Dominic Thorrington, Nick Andrews, Julia Stowe, Elizabeth Miller, Albert Jan van Hoek
Published 2018-02-01

Long-term sequelae of severe acute kidney injury in the critically ill patient without comorbidity: a retrospective cohort study.

by Gijs Fortrie, Susanne Stads, Albert-Jan H Aarnoudse, Robert Zietse, Michiel G Betjes
Published 2015-01-01

The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study.

by Albert Jan van Hoek, Anthony Underwood, Mark Jit, Elizabeth Miller, W John Edmunds
Published 2011-01-01

Quantifying the impact of social groups and vaccination on inequalities in infectious diseases using a mathematical model

by James D. Munday, Albert Jan van Hoek, W. John Edmunds, Katherine E. Atkins
Published 2018-09-01

Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes.

by Albert Jan van Hoek, Nick Andrews, Pauline A Waight, Robert George, Elizabeth Miller
Published 2012-01-01

The burden of disease and health care use among pertussis cases in school aged children and adults in England and Wales; a patient survey.

by Albert Jan van Hoek, Helen Campbell, Nick Andrews, Mariza Vasconcelos, Gayatri Amirthalingam, Elizabeth Miller
Published 2014-01-01

The social life of infants in the context of infectious disease transmission; social contacts and mixing patterns of the very young.

by Albert Jan van Hoek, Nick Andrews, Helen Campbell, Gayatri Amirthalingam, W John Edmunds, Elizabeth Miller
Published 2013-01-01

Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands

by van Lier Alies, van Hoek Albert Jan, Opstelten Wim, Boot Hein J, de Melker Hester E
Published 2010-08-01

Optimisation of the sensitivity of an immunoassay analysis for tobramycin in serum

by Marcel Hoppentocht, Onno W. Akkeman, Albert-Jan Voerman, Ben Greijdanus, Daan J. Touw, Jan-Willem C. Alffenaar
Published 2015-10-01

Development and evaluation of the oligonucleotide ligation assay (OLA) for the detection of drug resistance mutations in HIV-2 patients on antiretroviral therapy

by Vanham Guido, Albert Jan, Brandin Eleanor, Kaye Steve, Jallow Sabelle, Whittle Hilton, Rowland-Jones Sarah, Janssens Wouter
Published 2006-12-01

The effect of measles on health-related quality of life: a patient-based survey.

by Dominic Thorrington, Mary Ramsay, Albert Jan van Hoek, W John Edmunds, Roberto Vivancos, Antoaneta Bukasa, Ken Eames
Published 2014-01-01

Cost–benefit analysis of surveillance for surgical site infection following caesarean section

by Catherine Wloch, Albert Jan Van Hoek, Nathan Green, Joanna Conneely, Pauline Harrington, Elizabeth Sheridan, Jennie Wilson, Theresa Lamagni
Published 2020-07-01

Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands.

by Dominic Thorrington, Leo van Rossum, Mirjam Knol, Hester de Melker, Hans Rümke, Eelko Hak, Albert Jan van Hoek
Published 2018-01-01

Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.

by Stefan Flasche, Albert Jan Van Hoek, Elizabeth Sheasby, Pauline Waight, Nick Andrews, Carmen Sheppard, Robert George, Elizabeth Miller
Published 2011-04-01

Correction: A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison between Rotarix and RotaTeq Vaccines

by Albert Jan van Hoek, Mwanajuma Ngama, Amina Ismail, Jane Chuma, Samuel Cheburet, David Mutonga, Tatu Kamau, D. James Nokes
Published 2012-01-01

A cost effectiveness and capacity analysis for the introduction of universal rotavirus vaccination in Kenya: comparison between Rotarix and RotaTeq vaccines.

by Albert Jan van Hoek, Mwanajuma Ngama, Amina Ismail, Jane Chuma, Samuel Cheburet, David Mutonga, Tatu Kamau, D James Nokes
Published 2012-01-01

Correction: A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison between Rotarix and RotaTeq Vaccines.

by Albert Jan van Hoek, Mwanajuma Ngama, Amina Ismail, Jane Chuma, Samuel Cheburet, David Mutonga, Tatu Kamau, D. James Nokes
Published 2012-01-01